International Edition
Latest News
Health

Inoperable Pancreatic Cancer: Chemo May Enable Surgery, Mayo Clinic Says

Pancreatic cancer patients told their tumors are inoperable because of blood-vessel involvement may still have surgical options after chemotherapy, Mayo Clinic specialists said. The shift reflects wider use of preoperative chemotherapy and advanced vascular reconstruction, which can convert…

Pancreatic cancer patients told their tumors are inoperable because of blood-vessel involvement may still have surgical options after chemotherapy, Mayo Clinic specialists said.

The shift reflects wider use of preoperative chemotherapy and advanced vascular reconstruction, which can convert some locally advanced cases to resectable ones, according to a Mayo Clinic Q&A published Nov. 19 by Mark Truty, M.D., a surgeon in Rochester, Minnesota.

Locally advanced pancreatic cancer — tumors that have not spread to distant organs but encase nearby veins or arteries — occurs in up to one-third of patients at diagnosis, Truty said. Historically, these patients were not offered surgery because of the complexity of vascular resection and reconstruction.

Today, more effective chemotherapy regimens and refined surgical techniques allow selected patients to undergo vein or artery removal and reconstruction, or both, after their tumors respond to treatment, the Mayo Clinic Q&A stated.

Giving chemotherapy before surgery serves two purposes, Truty said. It treats microscopic disease not visible on imaging, and it provides a real-time test of tumor biology. Patients whose cancers shrink or stabilize on therapy may become candidates for operations that were initially deemed too risky.

“Surgical candidacy may change over the course of treatment rather than being determined only by a scan at diagnosis,” Truty said. Increasingly, chemotherapy is given before surgery. Pancreatic cancer can spread at a microscopic level that cannot be seen on imaging. Chemotherapy can treat cancer cells that may not be visible.

Evaluation at a high-volume pancreatic center can confirm the original recommendation or identify vascular-reconstruction options the first team did not offer, the Q&A noted. The goal is not to operate because it is technically possible, but to determine whether surgery combined with other treatments offers a meaningful survival and quality-of-life benefit for that individual.

Factors include the extent of cancer, treatment response, surgical complexity, the patient’s overall health, and the potential to prolong life and improve quality of life, the Mayo Clinic Q&A stated.

Patients told their pancreatic cancer is inoperable should seek a second opinion at a center with extensive experience in complex pancreatic surgery, Truty said. Understanding why surgery was ruled out — and whether preoperative therapy could alter that assessment — can open options that did not exist a decade ago.

Ultimately, it is important to get a second opinion when diagnosed with pancreatic cancer. A second opinion does not mean another surgeon will recommend an operation. Another evaluation may confirm that the treatment plan already received is the right one.

About the author: Health Desk

Health Desk at Archynewsy.